Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 22 for “"Chemo-sensitivity"”.

  1. ANNEXIN-A1, A NOVEL BIOMARKER PREDICTS CHEMO-SENSITIVITY TO PPAR-¿ AGONIST THERAPY IN TRIPLE-NEGATIVE BREAST CANCER

    Chemotherapy is standard of care for treating cancer and controlling tumor progression. However, chemotherapeutic drugs can display a multitude of side effects. An ongoing challenge is to find improved methods of identifying and classifying groups of tumors with differing biological behaviors or …

    nus Repository record for ANNEXIN-A1, A NOVEL BIOMARKER PREDICTS CHEMO-SENSITIVITY TO PPAR-¿ AGONIST THERAPY IN TRIPLE-NEGATIVE BREAST CANCER (opens in a new tab) Download file for ANNEXIN-A1, A NOVEL BIOMARKER PREDICTS CHEMO-SENSITIVITY TO PPAR-¿ AGONIST THERAPY IN TRIPLE-NEGATIVE BREAST CANCER (opens in a new tab)

  2. Omega-3 Fatty Acids as Therapeutic Options for the Treatment of B-cell Chronic Lymphocytic Leukemia

    … CLL or enhance the effects of actively used chemo-therapeutic drugs in patients who require therapy would be clinically beneficial. In our studies, we evaluated the use of omega-3 (n-3) fatty acids as therapeutic options for CLL utilizing both a clinical supplementation model (FWA #00002704) …

    marshall Repository record for Omega-3 Fatty Acids as Therapeutic Options for the Treatment of B-cell Chronic Lymphocytic Leukemia (opens in a new tab)

  3. On a stochastic particle model of the Keller-Segel equation and its macroscopic limit

    … the two-dimensional Keller-Segel equation for chemo- taxis from a stochastic system of N interacting particles in the situation in which bounded solutions are guaranteed to exist globally in time, that is in the case of subcritical chemo- sensitivity

    lmu-germany Repository record for On a stochastic particle model of the Keller-Segel equation and its macroscopic limit (opens in a new tab)

  4. Pharmacogenomics of Chemotherapeutic Agents: Carboplatin and Paclitaxel

    … drugs are currently used as standard-of-care chemotherapy, often in combination with taxanes, for various cancers including lung cancer- the most common malignancy, and ovarian cancer- the most lethal gynecological malignancy. However, the overall response rate of carboplatin/paclitaxel-based …

    umn Repository record for Pharmacogenomics of Chemotherapeutic Agents: Carboplatin and Paclitaxel (opens in a new tab)

  5. Targeting Mitochondrial manganese superoxide dismutase to improve treatment of Breast carcinoma

    … an accumulation of mitochondria ROS and enhances chemo-sensitivity. Furthermore, we showed that PPAR? is under epigenetic regulation and that treatment with histone deacetyase inhibitors (HDACi) increases PPAR? acetylation status, activity and expression levels. Therefore, we propose a combination …

    nus Repository record for Targeting Mitochondrial manganese superoxide dismutase to improve treatment of Breast carcinoma (opens in a new tab) Download file for Targeting Mitochondrial manganese superoxide dismutase to improve treatment of Breast carcinoma (opens in a new tab)

  6. Enhancing The Efficacy Of Thymidylate Synthase Inhibitors By Genetic Modulation Or Pharmacological Inhibition Of Bone Marrow Derived Cells In The Tumor Stroma

    … affect the efficacy of tumor-directed chemotherapies. Tumors are now considered as complex organ consisting of both cancerous and noncancerous cells interacting with each other within the tumor microenvironment to promote malignancy. For decades, 5- fluorouracil (5-FU), an inhibitor of …

    south-carolina Repository record for Enhancing The Efficacy Of Thymidylate Synthase Inhibitors By Genetic Modulation Or Pharmacological Inhibition Of Bone Marrow Derived Cells In The Tumor Stroma (opens in a new tab)

  7. Autophagy in siRNA-mediated PRKAR1A knockdown canine osteosarcoma cells

    … be due to the ability of OSA cells to resist chemotherapy-induced cell death by entering autophagy. Autophagy, or “self-eating”, is an evolutionarily conserved intracellular catabolic process which plays an important role in adaptation to environmental changes and maintenance of cellular …

    guelph Repository record for Autophagy in siRNA-mediated PRKAR1A knockdown canine osteosarcoma cells (opens in a new tab)

  8. A microfluidic platform for functional assays on tumour biopsy-derived spheroids for precision medicine

    … and molecular diagnostics, as well as functional chemo-sensitivity screening assays. In recent years, the use and development of physiologically relevant patient-derived 3D in vitro cancer models has increased, since 3D ex vivo and in vitro models can replicate many aspects of the tumour …

    strathclyde Repository record for A microfluidic platform for functional assays on tumour biopsy-derived spheroids for precision medicine (opens in a new tab)

  9. Long Non-coding RNA PVT1 – An Exploratory Study in Ovarian and Endometrial Cancer

    … including doxorubicin metabolism, which impacts chemo sensitivity in ovarian cancer. We further investigated the role of PVT1 DNA alterations and RNA expression in endometrial cancer. We find that PVT1 has predictive value for survival and potentially treatment response. High PVT1 RNA expression …

    south-carolina Repository record for Long Non-coding RNA PVT1 – An Exploratory Study in Ovarian and Endometrial Cancer (opens in a new tab)

  10. The evaluation of the IGF-1R as a proposed biomarker for DNA damaging cancer therapies

    … survival. IGF-1R inhibition enhances radio- and chemo-sensitivity, potentially influencing DNA damage response, whilst IGF1R SNP rs4966013 has been identified as the SNP in the p53 stress response network most significantly associated with differences in chemosensitivity.</p> <p><u>Aims:</u> 1. …

    oxford Repository record for The evaluation of the IGF-1R as a proposed biomarker for DNA damaging cancer therapies (opens in a new tab)

  11. Disulfiram (Antabuse) acts as a potent chemo-radio sensitizer and abolishes stem cells in HNSCC cell lines in vitro

    … resistance of cancer stem cells (CSCs) to radio-chemotherapy. ALDH (Aldehyde Dehydrogenase) has been used as a marker to identify CSCs in several tumors including HNSCC. Disulfiram (DSF) is a pan-ALDH inhibitor, which has been found to have remarkable anti-cancer activity. Moreover, DSF is a …

    fu-berlin Repository record for Disulfiram (Antabuse) acts as a potent chemo-radio sensitizer and abolishes stem cells in HNSCC cell lines in vitro (opens in a new tab)

  12. From a Road Less Travelled to a Worn Path: Three-Dimensional Tumour Models for Cancer Research and Therapeutics

    … are not reliable tools for investigating chemo sensitivity of anti-cancer drug candidates.Therefore, the emerging miniaturized 3D tumour models in vitro are better representatives of thehuman tumour growing in the in vivo microenvironment. We have established a complex 3D humantumour …

    lund Repository record for From a Road Less Travelled to a Worn Path: Three-Dimensional Tumour Models for Cancer Research and Therapeutics (opens in a new tab) Download PDF for From a Road Less Travelled to a Worn Path: Three-Dimensional Tumour Models for Cancer Research and Therapeutics (opens in a new tab)

  13. Does the IGF axis influence EMT to play a role in bladder cancer progression?

    … including the development of resistance to chemotherapy. Epithelial-to-mesenchymal transition (EMT) and high insulin-like growth factor (IGF)-activity have been reported to facilitate tumour development in many cancer types including bladder. Insulin-like growth factor binding protein 2 …

    bristol Repository record for Does the IGF axis influence EMT to play a role in bladder cancer progression? (opens in a new tab) Download PDF for Does the IGF axis influence EMT to play a role in bladder cancer progression? (opens in a new tab)

  14. Proteomic Investigation of Endocrine Therapy Resistance in Breast Cancer Investigating the Molecular Mechanisms for SERM Resistant Cell Lines Using SILAC-Based Proteomic Approach

    … to endocrine treatment. Method: In vitro chemo-sensitivity (IC50) was determined for MCF7, T47D, MDA-MB-231, MDA-MB-468, MDA-MB-453, BT-20 and MCF-10A breast cell lines using four endocrine-based therapeutic agents (Tamoxifen, 4-Hydroxytamoxifen OHT, Raloxifene, Anastrozole) to select …

    bradford Repository record for Proteomic Investigation of Endocrine Therapy Resistance in Breast Cancer Investigating the Molecular Mechanisms for SERM Resistant Cell Lines Using SILAC-Based Proteomic Approach (opens in a new tab)

  15. The development of 3D colorectal cancer models to test cancer therapies

    … for advanced or metastatic colorectal cancer is chemotherapy. This can take the form of mono-therapy with Capcitebine or oxaliplatin, in combination with 5-fluorocil (5-FU) and folinic acid. However, acquired drug resistance is a major issue and this can result in a decrease in therapeutic …

    whiterose Download PDF for The development of 3D colorectal cancer models to test cancer therapies (opens in a new tab)

  16. The intermediate filament synemin promotes non-homologous end joining in an ATM-dependent manner

    … matrix is a well-known determinant of radiochemo-resistance. It has been shown that targeting focal adhesion proteins (FAPs), e.g. β1 integrin, enhances tumor cell radio(chemo)sensitivity in various entities such as head and neck squamous cell carcinoma (HNSCC), lung carcinoma, glioblastoma, …

    qucosa-diss

Page 1 of 2